Skip to main content
Livermore
Livermore
ZHEN

ProMIS Neurosciences Inc.

PMN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001374339

In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding ProMIS Neurosciences Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of PMN: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders19123+5
Shares8.47M52.8K9.99M+1.57M (+18.7%)
Value$4.10M$25.6K$4.25M+$172.0K (+4.2%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held ProMIS Neurosciences Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to PMN in Q3 2025
InstitutionSharesValue% of portfolio
XTX Topco Ltd67,687$28.8K0.00%
HRT Financial LP68,057$28.0K0.00%
Two Sigma Investments, LP18,428$7.83K0.00%
Advisor Group Holdings, Inc.9,000$4.77K0.00%
UBS Group AG2,506$1.06K0.00%
North Star Investment Management Corp.500$2120.00%
Federation des caisses Desjardins du Quebec254$1060.00%
JPMorgan Chase & Co68$290.00%

Sold out (3)

Institutions that held ProMIS Neurosciences Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of PMN in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Great Point Partners LLC2,645,128$1.28M
Allostery Investments LP155,720$76.3K
Kingsview Wealth Management, LLC31,062$15.0K

Not filed for Q3 2025 yet (1)

Institutions that held ProMIS Neurosciences Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PMN in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Graypoint LLC52,833$25.6K